Unblocking the vaccine pipeline

New approaches for speeding vaccine discovery and development proposed

Written byJohn Dudley Miller
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

A pair of ideas discussed at the Sixth Annual Conference on Vaccine Research in Arlington, Va., promises to dramatically shorten the frustrating, decades-long process of discovering and testing new vaccines. Proponents believe the approaches could make it possible to develop a variety of vaccines years before they would otherwise become available.

Dramatically cutting initial discovery time can be accomplished by searching for potential antigens in the genome using a computer rather than in the lab using traditional methods, according to Rino Rappuoli, head of research and development at Chiron Vaccines in Sienna, Italy.

"The genome has provided us all we need, for every pathogen," said Rappuoli, the technique's pioneer. The "old method" of conducting years of painstaking basic lab research to understand a pathogen before creating its vaccine is no longer necessary, he claimed.

Speeding up vaccine development can also be accomplished by improving researchers' basic understanding of the manufacturing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery